10 results
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Insulin Analogs ... Acting - Onset, Peak ... , Duration #Diabetes ... #Comparison #Pharmacology ... #Endocrinology
Insulin - Comparison - Peak and Duration

#insulin #pharmacology #duration #peak #diabetes #endocrinology #Comparison
Insulin - Comparison ... - Peak and Duration ... #insulin #pharmacology ... #duration #peak ... #diabetes #endocrinology
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
principles of insulin ... and Duration #Diabetes ... #Duration #Peaks ... #Comparison #Pharmacology ... #Endocrinology
Insulin Comparison Chart

Insulin Types - Onset (hours) - Peak Glycemic Effect (hours) - Duration (hours)
 •
Insulin Comparison ... Chart Insulin ... Onset (hours) - Peak ... Comparison #Table #pharmacology ... #diabetes #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... SGLT2 inhibitors ... adverse CV events, Improved ... comparison #management #endocrinology
The graph illustrates the differences in the onset and duration of action for various types of
Detemir, Glargine #Diabetes ... #Insulin #Analogs ... #Duration #Peaks ... Graph #Comparison #Pharmacology ... #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... #Medications #pharmacology ... comparison #table #endocrinology
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications 

Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Norepinephrine Reuptake Inhibitors ... Cymbalta) - GAD, MDD, Diabetic ... Serotonin-Norepinephrine Reuptake Inhibitors ... #Indications #Pharmacology ... #Psychiatry #FDA
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... Canagliflozin) being approved ... Ertugliflozin) being approved ... #Pharmacology # ... #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
-> Stimulates Insulin ... will stimulate insulin ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology